A case of severe adolescent @entity3119 treated with inpatient hospitalization, @entity1090 and XXXX .

@entity1 @entity2700 @entity146 @entity914 @entity3756 @entity1245 @entity1017 @entity716 @entity209 @entity21 @entity3119 @entity1090
BACKGROUND: The initial treatment of @entity3119 ( @entity3119 ) has generally been limited to serotonergic agents, cognitive-behavioral therapy (CBT), or a combination of the two. These findings were supported by the POTS study for @entity3119 in @entity1 and adolescents. However, treatment with serotonergic agents or CBT can take several weeks before benefit is seen; severe cases of @entity3119 may require more immediate treatment. CASE REPORT: The authors present a case of severe @entity3119 in an adolescent that required immediate treatment due to her critical medical condition. The @entity1 's symptoms included not eating or taking medications or fluids by mouth due to fears of contamination. A medical hospitalization was previously required due to @entity2700 . As treatment with an SSRI would not have quick enough onset and the @entity1 was initially resistant to participating in CBT, the @entity1 was psychiatrically hospitalized and first started on liquid @entity1090 . After several doses of @entity1090 , the @entity1 was able to participate in CBT and start @entity3756 . DISCUSSION: The authors discuss the differential diagnosis of such a @entity1 , including the continuum of @entity3119 symptoms and @entity716 . The authors discuss the different treatment options, including the utilization of inpatient @entity146 hospitalization. The authors discuss the potential risks and benefits of using atypical antipsychotics in lieu of @entity1245 for the initial treatment of severe adolescent @entity3119 . The authors also discuss other current treatment recommendations and rationale for the treatment that was pursued. CONCLUSIONS: This @entity1 received benefit of her symptoms relatively quickly with @entity146 hospitalization and an atypical antipsychotic. The diagnosis of a @entity914 should be considered. These treatment options must be weighed against the risks of atypical antipsychotics, including @entity21 , @entity1017 , and @entity209 ; @entity1245 also have their risks and benefits. Additionally, the cost of time and finances of inpatient hospitalization must be considered. More research is needed regarding the short- and long-term efficacy and safety of antipsychotics in the treatment of @entity3119 in the @entity1 and adolescent population.
